The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 28, 2026

Filed:

Feb. 12, 2020
Applicant:

Insulet Corporation, Acton, MA (US);

Inventor:

Bryan Mazlish, Palo Alto, CA (US);

Assignee:

Insulet Corporation, Acton, MA (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61B 5/00 (2006.01); A61B 5/145 (2006.01); A61M 5/142 (2006.01); A61M 5/172 (2006.01); G16H 20/17 (2018.01);
U.S. Cl.
CPC ...
A61M 5/1723 (2013.01); A61B 5/14532 (2013.01); A61B 5/4839 (2013.01); A61M 5/14244 (2013.01); G16H 20/17 (2018.01); A61M 2005/14208 (2013.01); A61M 2205/18 (2013.01); A61M 2205/3553 (2013.01); A61M 2205/3561 (2013.01); A61M 2205/3584 (2013.01); A61M 2205/3592 (2013.01); A61M 2209/01 (2013.01); A61M 2230/201 (2013.01);
Abstract

A method of facilitating delivery of a discretionary dose of insulin to a user includes: enabling the user or a caregiver to specify, via a computer-based user interface, parameters associated with a discretionary delivery of insulin that may be delivered to the user; subsequently receiving data that represents the user's glucose level during a period of time associated with the discretionary delivery; automatically determining, with a computer-based processor, based on the received data, if, when and how much discretionary insulin should be delivered to the user during the period of time associated with the discretionary delivery; delivering insulin to the user during the period of time associated with the discretionary delivery according to the automatic determination; and delivering insulin to the user with the insulin delivery device according to a non-discretionary insulin delivery schedule unless a discretionary insulin delivery mode has been triggered.


Find Patent Forward Citations

Loading…